Global healthcare technology leader Medtronic has partnered with the Institute of Neurosciences Kolkata (I-NK) to strengthen the adoption of advanced neuromodulation therapies for the management of Parkinson’s disease and other movement disorders. The collaboration aims to enhance skill development among medical professionals and increase awareness of modern therapy options among clinicians and patients.
Parkinson’s disease remains a growing neurological challenge in East India. In cities such as Kolkata, the prevalence is estimated at 45.82 cases per 100,000 people, with a significant proportion of early-onset cases occurring before the age of 50. As treatment approaches evolve, neuromodulation therapies such as Deep Brain Stimulation (DBS) are emerging as key options for selected patients. Newer innovations including adaptive Deep Brain Stimulation (aDBS), which adjusts stimulation based on patient-specific neural signals, are expected to further personalise treatment outcomes.
Medtronic India Managing Director and Vice President Mandeep Singh Kumar said the partnership aims to build sustainable clinical capabilities in West Bengal through structured training and improved patient engagement. Meanwhile, the Institute of Neurosciences Kolkata has strengthened its neuromodulation capabilities with the acquisition of advanced Microelectrode Recording (MER) technology, enabling greater precision in movement disorder surgeries.
The partnership highlights the expanding neurology and neuromodulation market in Kolkata, which is emerging as a key healthcare hub for eastern and northeastern India. Rising awareness, improved diagnostics and growing patient demand are encouraging hospitals to adopt advanced treatment technologies. Industry stakeholders believe collaborations between global medical technology companies and specialised institutions like I-NK could accelerate the adoption of neuromodulation therapies and support the development of a regional Centre of Excellence for movement disorder care.
Dr Hrishikesh Kumar, Vice Chairman and Head of Neurology and Director of the Movement Disorders Program at I-NK, said increased clarity among clinicians and patients is essential as neuromodulation becomes an important part of neurological care. Doctors Bibhukalyani Das, Jacky Ganguly, Amit Kumar Ghosh and Supriyo Choudhury also stressed the need to develop a strong neuromodulation ecosystem in eastern India. With India carrying a large burden of Parkinson’s disease due to its population size, the initiative aims to strengthen clinical research, training and patient outcomes in the evolving neurological care landscape.
